U.K. Pharmaceuticals & Biotech Top Stock Picks from Analysts

Hikma Pharmaceuticals

Market Cap: UK£3.6b

Develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.

HUTCHMED (China)

Market Cap: UK£2.0b

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally.

Allergy Therapeutics

Market Cap: UK£395.6m

A commercial biotechnology company, focuses on the diagnosis and treatment of allergic disorders.

PureTech Health

Market Cap: UK£302.1m

Engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States.

Faron Pharmaceuticals Oy

Market Cap: UK£207.1m

Operates as a clinical stage drug discovery and development company.

Bioventix

Market Cap: UK£129.3m

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide.

4basebio

Market Cap: UK£112.2m

Engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and non-viral vector solutions in Europe, the United States, and internationally.

Scancell Holdings

Market Cap: UK£95.5m

A clinical stage biopharmaceutical company, discovers and develops of immunotherapies for the treatment of cancer in the United Kingdom.

Shield Therapeutics

Market Cap: UK£76.4m

A commercial stage specialty pharmaceutical company, focuses on development and commercialization of clinical-stage pharmaceuticals to treat unmet medical needs.

ECO Animal Health Group

Market Cap: UK£66.7m

ECO Animal Health Group plc, together with its subsidiaries, manufactured and supply animal health products internationally.

hVIVO

Market Cap: UK£52.4m

Operates as a pharmaceutical service and contract research company in the United Kingdom, Europe, and North America.

SkinBioTherapeutics

Market Cap: UK£40.4m

A life science company, engages in research and development, and commercialization of technology that harnesses the microbiome for human health in the United Kingdom, the United States, Europe, and internationally.

Arecor Therapeutics

Market Cap: UK£32.7m

A clinical stage biotechnology company, develops innovative medicines that address significant unmet patient needs in the United Kingdom.

Poolbeg Pharma

Market Cap: UK£27.2m

A clinical-stage biopharmaceutical company, focused on acquiring, developing, and commercialising of medicines for unmet medical needs in the United Kingdom.

Solvonis Therapeutics

Market Cap: UK£23.1m

A clinical-stage biopharmaceutical company, develops novel medicines for addiction and mental health disorders.

IXICO

Market Cap: UK£13.0m

Provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, the Netherlands, Ireland, rest of Europe, and the United States.

Futura Medical

Market Cap: UK£10.0m

Research, develops, and commercializes pharmaceutical and healthcare products for sexual health.

Verici Dx

Market Cap: UK£9.5m

Together with its subsidiary, Verici Dx Inc, develops prognostic and diagnostic tests for kidney transplant patients in the United Kingdom and the United States.

Theracryf

Market Cap: UK£4.6m

A clinical stage therapeutics company, engages in the development of therapeutics for oncology and behavioural brain disorders.